Wunderlich bumps PT on Symmetry Medical, sees 6% Implant and Cases growth


A PT hike to $11 from $10 at Wunderlich Securities may be helping Symmetry Medical shares (SMA +2.8%) higher.

Analyst James Terwilliger, which has a Buy rating on the name, believes 2014 revenue growth will be driven by a 6% boost in the Implant and Cases product lines.

On the balance sheet side, Terwilliger postulates that "management will remain focused on reducing debt levels."


From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs